U.S. General Merchandise and Department Stores Stock News

Popular (BPOP) just gave its shareholders a reason to pay attention. The Board of Directors has approved a quarterly cash dividend of $0.75 per share, payable this October. While dividend hikes might seem like routine fare for some companies, these moves often signal management's confidence in the business and its underlying earnings power. For investors wondering about Popular’s momentum, this dividend decision is a clear indication that the bank is focused on rewarding shareholders and...

Akero Therapeutics (AKRO) just revealed the final 96-week results from its Phase 2b HARMONY trial for efruxifermin, an investigational therapy for people living with MASH and significant liver fibrosis. The data, published in The Lancet, showed sustained improvements in fibrosis and markers of metabolic health. This is a meaningful milestone for patients and investors alike. Given the complexity of MASH and the unmet need for new treatments, this clinical update is likely to influence how the...

If you are tracking PJT Partners (PJT), this week’s headlines about record-breaking fund ABS issuance probably caught your eye. The company has highlighted a surge in asset-backed securities activity this year, noting how more asset managers are tapping into this corner of the fund finance world. As an adviser closely connected to these trends, PJT now finds itself in the spotlight, raising new questions about its potential to capture value from these evolving market dynamics. The share price...

Wyndham Hotels & Resorts (WH) has just debuted the redesigned Comwell Hvide Hus Aalborg, a 16-story landmark now operating under the Dolce by Wyndham brand in Denmark. This is not just any hotel update. It marks Wyndham’s fourth partnership with Comwell in Denmark and it arrives at a time when travelers are seeking authentic, experience-focused stays. From new signature dining concepts to flexible meeting spaces, the move aligns closely with current travel trends, and it shows that Wyndham is...

Marzetti (MZTI) grabbed the spotlight after its latest quarterly earnings, and for good reason. The company just posted record sales, growing both revenue and volume thanks to a stronger retail segment and successful licensing partnerships. However, the bottom line told a different story, as cost increases and restructuring expenses cut into profits. Operating margins also came in softer than hoped. Investors are now weighing the uptick in demand and fresh product launches against the...

If you have been following Federated Hermes (FHI), you have seen the latest surge in interest across the investment management industry. Sector-wide momentum is building behind growing assets under management and a new wave of institutional inflows. Federated Hermes is riding these tailwinds, thanks in part to its focus on technology and its willingness to expand into new, innovative products. These moves catch the attention of investors looking for long-term growth stories in a rapidly...

LivaNova (LIVN) is making headlines this week after announcing the commercial launch of its Essenz Perfusion System in China, following recent local regulatory approval. For investors, this move represents more than just a product expansion, as it positions LivaNova to enter the world’s second-largest market for heart-lung machines. With China’s extensive cardiac surgery needs and a technology-driven system co-developed with clinicians, this milestone could serve as a meaningful catalyst for...

Recent forecasts indicate that Employers Holdings is expected to face a 1.8% revenue decline over the next 12 months, along with reduced profitability from incremental sales and falling earnings per share. This outlook points to potential challenges for the company’s workers’ compensation insurance business and signals rising investor caution regarding its future earnings. We’ll examine how expectations for declining revenue and earnings may reshape Employers Holdings’ investment narrative...

EastGroup Properties (NYSE:EGP) just delivered news that will matter to anyone considering their options with the stock at this time. The company’s Board announced a 10.7% increase to its quarterly dividend, raising the payout to $1.55 per share. This represents more than just a strong quarter; it marks the 183rd consecutive quarterly cash distribution, reflecting a streak of dividend consistency and growth over 33 years. Actions like this can signal management’s confidence in the company’s...

Plexus (PLXS) just delivered an upbeat third-quarter report, catching the eye of investors with adjusted earnings per share outpacing expectations. The real story comes from broad revenue growth and a wave of new business. The company secured 41 manufacturing programs, which could potentially bring in an extra $250 million per year once they are fully operational. Additionally, Plexus management expressed optimism for the next quarter, projecting not only higher revenues but also improved...

If you’ve been eyeing NewAmsterdam Pharma (NasdaqGM:NAMS), the latest developments could make you pause and reassess next steps. This week, the company unveiled a dedicated oral solid dosage manufacturing suite in partnership with Piramal Pharma Solutions. This multi-million-dollar move is aimed at boosting production efficiency for its investigational fixed dose combination of obicetrapib and ezetimibe. The timing matters, as the facility is built to handle potential high demand if...

RXO (RXO) investors have a new curveball to consider. Johnson Fistel, PLLP has announced an investigation into whether the company or its top executives might have failed to disclose important information. This raises the possibility of federal securities law violations. For anyone holding RXO stock, this development could signal a shift in the risk profile, as legal scrutiny often prompts investors to reassess what they think they know about a company’s prospects. This latest legal spotlight...

Virtus Investment Partners (VRTS) just made a move that is likely to grab the attention of both long-time shareholders and those watching from the sidelines. The company’s Board of Directors has approved a new quarterly dividend of $2.40 per share, an increase of 7% from the previous payout. Changes like this often suggest management has a constructive view of future business conditions, especially when paired with a commitment to return additional cash to investors. This dividend increase...

Stagwell (STGW) just made headlines with its appointment of Margaret Key as Executive Director for Asia Pacific and CEO of Allison Asia. With more than 20 years of experience reshaping agency operations across the region, Key’s dual role signals a targeted push into the APAC market. The move stands out for investors watching how Stagwell plans to expand and integrate its capabilities in a part of the world where marketing and communications demand is growing. This leadership shift comes at a...

First BanCorp (FBP) is back in the headlines after a surge that followed Jerome Powell’s remarks at the Jackson Hole symposium. Powell hinted that the Federal Reserve may be looking at rate cuts as inflation shows signs of cooling and unemployment remains low. For regional banks like First BanCorp, this was a cue: investors worried about the pressure of high rates quickly shifted gears, sending shares higher as sentiment across the sector improved. Looking at the past year, First BanCorp’s...

Chefs' Warehouse (CHEF) is getting a lot of attention lately, and for good reason. Recent reports have bumped its earnings outlook higher, with analysts pointing to strengthening growth metrics and revised earnings estimates for the current year. The company now boasts a top stock ranking from Zacks and a projected EPS jump of 19% this year, well ahead of its sector. For investors weighing whether to get in or stay on the sidelines, these numbers and the buzz around them are hard to...

If you have been keeping an eye on Euronet Worldwide (EEFT), this past week’s jump in the share price might have you reevaluating your game plan. The real spark appears to be Jerome Powell’s comments at the Jackson Hole symposium, hinting that the Federal Reserve could soon shift toward lower interest rates. Those remarks lit a fire under a range of financials, with Euronet among the names that rallied as investors recalibrated for a potentially more forgiving rate environment. While...

If you keep an eye on regional banks, the latest move in First Financial Bancorp (FFBC) may have caught your attention. Following dovish signals from Federal Reserve Chair Jerome Powell at the Jackson Hole symposium, FFBC and its peers saw an uptick as investors responded positively to the idea of potential rate cuts. Because regional banks are especially sensitive to Fed policy, the prospect of lower rates has sparked new optimism around earnings and sector profitability. This momentum...

J&J Snack Foods (JJSF) just made waves with news that its subsidiary, Dippin' Dots, is now the exclusive frozen treat provider at Urban Air Adventure Park locations nationwide. This fresh partnership puts Dippin' Dots in front of families at more than 350 adventure parks, giving the brand a foothold in one of the country’s busiest family entertainment destinations. For investors, the collaboration offers expanded reach in a fast-growing space, which could result in increased sales and...

If you have been keeping an eye on Middleby (MIDD), you probably noticed the recent buzz around its latest debt financing move. On August 19, Middleby extended the maturity date of its well-established credit agreement and smoothed the path for its long-planned separation of the food processing business. By securing more flexibility and additional time for this restructuring, the company has sent a clear message to investors that its management is making deliberate moves to unlock growth and...

If you’ve been keeping Healthcare Services Group (HCSG) on your watchlist, the latest surge in optimism around the stock is hard to ignore. The company has earned a top “Strong Buy” rank from Zacks and is attracting more investor attention by the week. What’s behind this renewed enthusiasm? In the past two months, analyst consensus estimates for full-year earnings have moved up nearly 5%. This suggests that those tracking HCSG closely are seeing something positive in its fundamentals. This...

Cytokinetics (CYTK) just announced it will present fresh data from aficamten’s key clinical trials, including the highly anticipated MAPLE-HCM study at the upcoming European Society of Cardiology Congress 2025. For investors who closely watch biotech catalysts, this moment is one that could shape not just market sentiment but the company’s growth story, as the spotlight lands firmly on aficamten’s potential in treating obstructive hypertrophic cardiomyopathy. With a follow-up investor webcast...

Savvy investors watching education finance stocks may have noticed shares of Nelnet (NNI) reaching fresh heights, after Federal Reserve Chair Jerome Powell’s comments signaled that interest rates could be cut soon. That news triggered a 4.8% jump for Nelnet, a move that stands out compared to typical trading days. The market’s reaction highlights the degree of confidence investors have in Nelnet’s financial outlook when borrowing costs might drop, even if nothing fundamental about the company...

If you’ve been tracking PTC Therapeutics (PTCT) lately, you know why investors are on edge. The FDA just issued a Complete Response Letter for PTC’s vatiquinone drug, indicating that more studies are required to demonstrate sufficient efficacy in treating Friedreich's ataxia. For a company with much of its pipeline built around high-risk, high-reward therapies, any regulatory setback like this demands a closer look, especially when it impacts one of their flagship development...